Type 2 diabetes trials in China

In China 189 Also abroad 1200

189 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 4Taking people
Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control
Where
Tianjin
Age
18 years to 75 years
People
430
Run by
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
See details and how to joinNCT07244003
Phase 3Not yet taking people in China
DPP4 Inhibitor Intervention on Post-stroke Cognitive Impairment in Ischemic Stroke Patients With Type 2 Diabetes
Where
Suzhou
Age
40 years to 75 years
People
312
Run by
Second Affiliated Hospital of Soochow University
See details and how to joinNCT07241897
Phase 4Not yet taking people in China
Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
Where
Shanghai
Age
18 years and over
People
1,244
Run by
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
See details and how to joinNCT07116928
No phaseNot yet taking people in China
Cofrogliptin and Linagliptin as add-on Therapy to Insulin in Type 2 Diabetes
Where
Baoding, Beijing, Hangzhou, Shanghai, Xi'an
Age
18 years and over
People
594
Run by
Yanbing Li
See details and how to joinNCT07198932
Phase 1Taking people
MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema
Where
Changsha, Chengdu, Shanghai
Age
18 years and over
People
45
Run by
Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.
See details and how to joinNCT04187443
No phaseNot yet taking people in China
A Multicenter, Randomized, Open-Label, Parallel-Controlled Clinical Study Comparing the Efficacy and Safety of Cofrogliptin Versus Acarbose in Drug-Naïve Patients With Type 2 Diabetes
Where
Zhengzhou
Age
18 years and over
People
200
Run by
Haisco Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07122102
Phase 3Taking people
Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus
Where
Beijing
Age
18 years to 75 years
People
360
Run by
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
See details and how to joinNCT07193459
No phaseTaking people
Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM
Where
Xuzhou
Age
25 years to 70 years
People
300
Run by
The Affiliated Hospital of Xuzhou Medical University
See details and how to joinNCT06256419
Phase 4Not yet taking people in China
The Effect of Semaglutide on Bone Health
Where
Xiamen
Age
50 years to 75 years
People
150
Run by
The First Affiliated Hospital of Xiamen University
See details and how to joinNCT07165158
Phase 4Taking people
Efficacy and Safety of Henagliflozin Proline and Metformin Hydrochloride Extended-release Tablets (Ⅰ) Versus Metformin Tablets in Patients With New-onset Type 2 Diabetes: a Multicenter, Randomized Controlled Study
Where
Hangzhou
Age
18 years to 75 years
People
268
Run by
Zhejiang Provincial People's Hospital
See details and how to joinNCT06888050
Phase 3Not yet taking people in China
A Phase 3 Study of HS-20094 in Patients With T2DM Inadequately Controlled With Diet and Exercise Alone
Where
Beijing
Age
18 years and over
People
204
Run by
Jiangsu Hansoh Pharmaceutical Co., Ltd.
See details and how to joinNCT07156500
Phase 3Not yet taking people in China
A Phase 3 Study of HS-20094 in Patients With T2DM
Where
Jinan, Tianjin
Age
18 years and over
People
546
Run by
Jiangsu Hansoh Pharmaceutical Co., Ltd.
See details and how to joinNCT07156539
No phaseTaking people
Efficacy of Glycemic Improvement Project (GLITTER Study) in Type 1 Diabetes-GLITTER Study 2
Where
Beijing, Changsha, Chengdu, Hangzhou, Luoyang, Quanzhou, Shenyang, Shenzhen, Tangshan, Wuhan
Age
6 years and over
People
400
Run by
Second Xiangya Hospital of Central South University
See details and how to joinNCT07097818
Phase 3Not yet taking people in China
A Study of RAY1225 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone
Where
Beijingcun
Age
18 years and over
People
350
Run by
Guangdong Raynovent Biotech Co., Ltd
See details and how to joinNCT07139535
Phase 3Not yet taking people in China
A Study of RAY1225 Versus Semaglutide as Add-on Therapy to Oral Antidiabetic Drugs in Participants With Type 2 Diabetes
Where
Beijing
Age
18 years and over
People
600
Run by
Guangdong Raynovent Biotech Co., Ltd
See details and how to joinNCT07139548
Phase 2Taking people
A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or Metformin
Where
Beijing
Age
18 years to 65 years
People
216
Run by
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
See details and how to joinNCT07109700
No phaseTaking people
The Application of an AI-driven Multimodal Predictive Model for Cognitive Impairment in Patients With Type 2 Diabetes Mellitus
Where
Enshi, Huanggang, Huangshi, Jingzhou, Shiyan, Suizhou, Wuhan, Xiangyang, Xianning, Xiantao, Xiaogan, Yichang
Age
40 years to 75 years
People
5,000
Run by
Tongji Hospital
See details and how to joinNCT07128186
No phaseTaking people
Hybrid Closed-Loop for Perioperative Glycemic Control in T2DM With Parenteral Nutrition
Where
Changsha
Age
18 years and over
People
40
Run by
Second Xiangya Hospital of Central South University
See details and how to joinNCT07121504
No phaseTaking people
Radiomics of Intra-abdominal and Subcutaneous Adipose Tissue Predict the Efficacy of Bariatric Surgery (RISABS)
Where
Beijing
Age
16 years to 70 years
People
800
Run by
China-Japan Friendship Hospital
See details and how to joinNCT06169033
No phaseNot yet taking people in China
To Observe the Clinical Effect of Femoral Nerve Block With Low Concentration of Ropivacaine Based on DPN Grading
Where
Taiyuan
Age
55 years to 85 years
People
60
Run by
Zheng Guo
See details and how to joinNCT06732362
No phaseTaking people
Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease
Where
Changsha, Yichang
Age
18 years to 75 years
People
120
Run by
State Key Laboratory of Subhealth Intervention Technology
See details and how to joinNCT05439226
Phase 3Taking people
A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus
Where
Yueyang
Age
18 years to 75 years
People
800
Run by
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
See details and how to joinNCT07082114
No phaseTaking people
Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease (Version 3.0)
Where
Changsha, Yichang
Age
18 years and over
People
120
Run by
State Key Laboratory of Subhealth Intervention Technology
See details and how to joinNCT07083336
Phase 4Taking people
The Effects of Henagliflozin on Glucose Fluctuation and Immunosenescence in Type 2 Diabetes Patients on Insulin Therapy
Where
Shanghai
Age
50 years to 70 years
People
64
Run by
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06818851
No phaseTaking people
County Medical Community-based, Cardiovascular Risk Stratified Integrated Care Model: a Pragmatic Cluster Randomised Control Trial
Where
Liuzhou, Sanming
Age
40 years to 70 years
People
2,560
Run by
Peking University
See details and how to joinNCT06302127